Table 4.
Multivariate analysis of factors that affect time to immunological recovery among 427 patients initiating ART at JCRC, during 2002–2006
| Variables |
Adjusted Hazard ratio |
95% CI | p-value |
| Group status | |||
| Non-ADC | 1.00 | ||
| ADC | 1.31 | 1.03–1.28 | 0.028 |
| CD4(cells/μl) | |||
| >200 | 1.00 | ||
| ≤ 200 | 0.52 | 0.37–0.77 | 0.001 |
| Viral load(copies log10/ml) | |||
| < 6.0 | 1.00 | ||
| ≥ 6.0 | 0.91 | 0.90–1.04 | 0.806 |
| Age(years) | |||
| ≤ 40 | 1.00 | ||
| > 40 | 1.11 | 0.81–1.67 | 0.504 |
| Sex | |||
| Male | 1.00 | ||
| Female | 1.18 | 0.85–1.67 | 0.334 |
| Adherence level(%) | |||
| < 95 | 1.00 | ||
| ≥ 95 | 2.22 | 1.57–3.15 | 0.001 |
| Total lymphocyte count (cells/mm3) × 103 | |||
| <1200 | 1.00 | ||
| ≥ 1200 | 1.84 | 1.22–2.78 | 0.003 |